Chief Transformation Officer ECRI
Bevin O’Neil is Chief Transformation Officer at ECRI, the independent nonprofit organization advancing patient safety worldwide through a systems approach and Just Culture. She leads ECRI’s Transformation Office — spanning corporate strategy, corporate development, product strategy, data and analytics products, and global commercial operations — and sits on ECRI’s Senior Leadership Team.
Ms. O’Neil brings a combination that’s rare in healthcare operating leadership: two decades of principal investing and global health experience paired with hands-on transformation execution. Before joining ECRI, she deployed $1.1 billion of private equity capital across $6.7 billion of enterprise value at Avista Capital Partners, leading healthcare carve-outs from corporate sellers including Bristol-Myers Squibb. Earlier in her career, she worked across the global health system from the top down and the ground up — partnering with major funders and policymakers, including WHO, the Global Fund, CDC, and USAID, at the Clinton Health Access Initiative to expand access to pediatric HIV treatment and diagnostics in low- and middle-income countries.
At ECRI, she has applied that transaction discipline directly to the organization’s future: through the sell-side divestiture of the Spend and Recall Management business of ECRI to Accel-KKR, ECRI narrowed its focus and shed complexity to double down on its core mission of reducing preventable harm. She also sourced and closed ECRI’s acquisition of The Just Culture Company. She now leads ECRI’s work building new data, AI, and digital capabilities that turn the organization’s proprietary patient-harm data into products that help health systems reduce preventable harm.
Ms. O’Neil has sat on several boards, audit and compensation committees, and holds a B.B.A. in Finance & Accounting from the University of Michigan.
